Retatrutide Peptide

Triple Agonist (GLP-1/GIP/GCGR)|High-Potency Research Peptide Lag luam wholesale
Khoom npe: Retatrutide hmoov
Cov tsos mob: Dawb hmoov
Cov mis mos molecular: C221h342n46o68
Molecular Luj: 4731.33
Test Method: HPLC
CAS Nr .: 2381089-83-2
Daim ntawv pov thawj: COA, MSDS, FDA, ISO9001, Halal, Kosher
Lub sij hawm xa tuaj: DHL, FEDEX, UPS, USPS, ob npaug - kev cai clearance (Qhov rooj rau qhov rooj);
Tshuag: Hauv Tshuag
Cia: ruaj khov ntawm 2-8 degree, tab sis yuav tsum tau khaws cia ntawm -20℃rau lub sijhawm ntev cia, nyiam dua desicated.

Retatrutide yog ntau- phiaj xwm incretin receptor agonist tsim los txhawb kev tswj qhov hnyav. Nws ua haujlwm los ntawm ib txhij ua kom cov receptors rau GLP-1, GIP, thiab glucagon-tseem ceeb regulators ntawm lub zog metabolism thiab qab los noj mov.

Raws li fatty -acylated ib leeg- saw peptide, rettrutide khi rau thiab qhib peb receptors: GCGR (glucagon receptor), GIPR (qabzib{2}}nyob ntawm insulinotropic polypeptide receptor), thiab GLP-1R (glucagon{7} receptor). Nws cov txheej txheem tsim kho fatty acid sab saw txuas ntxiv lub sijhawm ntawm cov molecule hauv cov hlab ntsha, tso cai rau noj ib zaug ib lub lim tiam.

Muaj nuj nqi & Siv

1. Txhawb kom muaj rog rog:

Txhawb kev tawg ntawm cov roj khaws cia los ntawm kev ua kom cov glucagon receptors, nce kev siv zog.

2.Suppress qab los noj mov:

Ncua lub plab khoob, txo cov zaub mov noj, thiab txo qis hauv nruab nrab kev tshaib kev nqhis.

3. Tswj cov metabolism:

Txhim kho insulin rhiab heev thiab txo qhov kev pheej hmoo ntawm cov ntshav qab zib hloov pauv.

Daim ntawv thov

Hauv kev tshawb fawb 48-lub lim tiam, Retatrutide ua tiav qhov hnyav poob ntawm 24.2%, ua haujlwm tau zoo dua qub GLP-1 receptor agonists. Nws yog tam sim no feem ntau siv rau kev kho mob rog.